Scancell Holdings (SCLP)


Latest News

Scancell gets European patent protection for immunotherapy platform

Immunotherapy developer Scancell Holdings said the European Patent Office would grant a patent for its Moditope immu...

Grant of European patent for Moditope platform

RNS Number: 9505O Scancell Holdings Plc 23 May 2018 23 May 2018 Scancell Holdings Plc ("Scancell" or the "Company") Scancell announces grant of European patent for its Moditope immunotherapy platform Scancell Holdings plc, the developer of novel immunotherapies for the treatment of cancer, confirms that following its announcement on 9 February 2018, ...

Holding(s) in Company

RNS Number: 8416N Scancell Holdings Plc 11 May 2018 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Scancell Holdings Pl...

Holding(s) in Company

RNS Number: 4945N Scancell Holdings Plc 09 May 2018 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Scancell Holdings plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights X An acqu...

All News

23-05-18Scancell gets European patent protection for immunotherapy platformStockMarketWire
23-05-18Grant of European patent for Moditope platformRNS
11-05-18Holding(s) in CompanyRNS
09-05-18Holding(s) in CompanyRNS
08-05-18Result of the Open Offer and PDMR ShareholdingsRNS
23-04-18Holding(s) in CompanyRNS
20-04-18Holding(s) in CompanyRNS
18-04-18Result of Placing and Subscription and PDMRRNS
18-04-18Second Price Monitoring ExtnRNS
18-04-18Price Monitoring ExtensionRNS
18-04-18Scancell Holdings launches £6m share issue to fund R&DStockMarketWire
18-04-18Technology acquired from University of NottinghamRNS
18-04-18Proposed Placing, Subscription and Open OfferRNS
03-04-18Scancell signs up PolyPeptide Group to manufacture vaccineStockMarketWire
03-04-18Manufacturing agreement with The PolyPeptide GroupRNS
20-02-18A small-cap planning a breakout moveInteractive Investor
19-02-18Trends and Targets for 20/02/2018Trends and Targets
16-02-18Scancell to present at the Calculus Investor ForumRNS
15-02-18Scancell signs agreement with ISA PharmaceuticalsStockMarketWire
15-02-18Hardman Res. - Validating multiple opportunitiesRNS
15-02-18Collaboration agreement with ISA PharmaceuticalsRNS
12-02-18Scancell collects positive results from cancer treatment trialStockMarketWire
12-02-18Publication highlights potential of SCIB1 therapyRNS
11-02-18Trends and Targets for 12/02/2018Trends and Targets
09-02-18Scancell patent application for Moditope granted in EuropeStockMarketWire
09-02-18European patent application allowed for grantRNS
08-02-18Scancell member of team shortlisted for CRUK awardRNS
01-02-18Director/PDMR ShareholdingRNS
30-01-18Scancell Holdings losses widenStockMarketWire
30-01-18Half-year ReportRNS
09-01-18Scancell to collaborate with BioNTechRNS
14-12-17Scancell forms partnership with Cancer ResearchStockMarketWire
14-12-17Scancell and CRUK to advance cancer immunotherapyRNS
07-12-17Trends and Targets for 8/12/2017Trends and Targets
11-10-17Result of AGMRNS
10-10-17Directorate ChangeRNS
14-09-17Notice of AGMRNS
13-09-17Weak mining and consumer stocks hit FTSEStockMarketWire
13-09-17Scancell reports good progress in development of Modi-1StockMarketWire
13-09-17Final ResultsRNS

RSS feeds

  • Editorial news feed for LSE:SCLP Editorial
  • Regulatory news feed for LSE:SCLP Regulatory